About the Company
CohBar is a clinical stage biotechnology company focused on the research and development of mitochondria based therapeutics, an emerging class of drugs for the treatment of chronic and age-related diseases. Mitochondria based therapeutics originate from the discovery by CohBar's founders of a novel group of naturally occurring peptide sequences within the mitochondrial genome, some of which have been shown to have the potential to regulate key processes in multiple systems and organs in the body. To date, the company has discovered more than 100 mitochondrial derived peptides and generated over 1,000 analogs. CohBar's efforts focus on the development of these peptides into therapeutics that offer the potential to address a broad range of diseases because of the underlying impact of mitochondrial dysfunction. The company's lead compound, CB4211, is in the Phase 1b stage of a Phase 1a/1b clinical trial for NASH and obesity. In addition, CohBar has 4 preclinical programs: CB5138 Analogs for fibrotic diseases, CB5064 Analogs for COVID-19 associated ARDS, MBT5 Analogs for CXCR4-related cancer and orphan diseases, and MBT3 Analogs for cancer immunotherapy.
Employees
12
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $CWBR News
CohBar, Inc. (CWBR) Stock Historical Prices & Data - Yahoo Finance
*Close price adjusted for splits.**Adjusted close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...
CohBar Announces Extension of Nasdaq Compliance Period and Summarizes 2022 Annual Meeting Proposal
CohBar, Inc. (NASDAQ: CWBR) (the “Company”), a clinical stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential ...
CohBar, Inc. (CWBR) Stock Price, News, Quote & History - Yahoo Finance
MENLO PARK, Calif., November 27, 2023--On November 20, 2023, CohBar, Inc. (the "Company") was notified by the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") ...
CohBar, Inc. (CWBR)
MENLO PARK, Calif., November 27, 2023--On November 20, 2023, CohBar, Inc. (the "Company") was notified by the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") ...
Aligos Therapeutics Strengthens Finance Leadership Team with Two New Appointments
She joins from ABio-X Holdings - Inc. where she was instrumental in building a new life science incubator. Previously, Jordyn served as the Head of Investor Relations at CohBar, Inc., a company ...
Why PacWest Bancorp Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket
BuzzFeed, Inc. (NASDAQ: BZFD) shares dropped 11.7% to $1.13 in pre-market trading after the company issued weak first-quarter guidance. CohBar, Inc. (NASDAQ: CWBR) fell 11.2% to $1.50 in pre ...
Welcome to Inc.'s Directory of B2B Excellence
They all made it through Inc.'s proprietary vetting process, based in part on testimonials from other clients. As any entrepreneur knows, the right partnership can make all the difference.
Snap Inc Class A
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.67%
The worst performers were CohBar Inc (NASDAQ:CWBR) which was down 47.73% to 0.92 in late trade, Tempo Automation Holdings Inc (NASDAQ:TMPO) which lost 44.46% to settle at 0.05 and Tenon Medical ...
STIHL Inc.
This company has paid to receive expanded profile features. About STIHL Inc. Virginia-based STIHL Inc. is the U.S. affiliate for the global STIHL group and the manufacturer of the number one ...
Enveric Biosciences, Inc. (ENVB)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Aligos Therapeutics Strengthens Finance Leadership Team with Two New Appointments
She joins from ABio-X Holdings - Inc. where she was instrumental in building a new life science incubator. Previously, Jordyn served as the Head of Investor Relations at CohBar, Inc., a company ...
Loading the latest forecasts...